An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies ​are expected to go public amid a ...

The SFDA reported that approximately 2,700 patients have benefited from access to innovative and advanced treatments through ...

Guanidine is an organic compound primarily used as a denaturing reagent to disrupt the structures of proteins and nucleic ...

Researchers studying cyanobacteria from hot springs in Thailand have discovered a new natural UV-blocking compound with ...

Firm's vision is to harness power of microorganisms as a sustainable platform to produce proteins now derived from animals ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...

Romania has received the 18th positive opinion out of the 25 required for accession to the OECD, namely that of the Chemicals ...

GEA has teamed up with Bio Factory to deliver a precision and biomass fermentation line at the latter's open-access facility ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...